AB-kefir modulates gut microbiota and ameliorates obesity, metabolic and vascular insulin resistance in high-fat diet-induced obese rats
Journal of Functional Foods · 2025-05 · 128 · 106802
DOI: 10.1016/j.jff.2025.106802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2025-05. Verfasst von Yahkub Babatunde Mutalub und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Sains Malaysia.
Abstract (Originalsprache)
Kefir is gaining popularity worldwide as a probiotic. This study investigated the effect of AB- Kefir on body weight and metabolic and vascular insulin resistance in high-fat diet-induced obese rats focusing on gut microbiota modulation. Twenty-four Sprague-Dawley rats were divided into three groups receiving either a normal chow or a high-fat diet (HFD) for 14 weeks and subsequently gavaged with AB-Kefir probiotics or an equivalent volume of water for eight weeks. AB-Kefir reduced body weight, body mass index (BMI), fasting blood glucose (FBG), and insulin levels. It also improved the metabolic insulin resistance and sensitivity and reverted the impaired insulin-induced aortic relaxation in obese rats. In addition, AB-Kefir altered the microbiota composition by reducing Actinobacteria and increasing Firmicutes - Lactobacillaceae and Ruminococcaceae . These data suggest a potential therapeutic role for AB-Kefir in attenuating the insulin resistance commonly associated with cardiovascular and metabolic disorders related to obesity. • A high-fat diet leads to obesity in rats, which is associated with both metabolic and vascular insulin resistance, and it also alters the composition of the gut microbiota. • AB-Kefir alleviates obesity and reduces metabolic and vascular insulin resistance in obese rats. • AB-Kefir modulates gut microbiota composition in obese rats. • AB-Kefir has the potential to manage obesity and associated metabolic and vascular complications.
Förderung
- Universiti Sains Malaysia
Zitieren
APA
Mutalub, Y. B., Azemi, A. K., Suhaimi, S. Q. A., Rasool, A. H. G., Tang, S. P., Lee, C., & Mokhtar, S. S. (2025). AB-kefir modulates gut microbiota and ameliorates obesity, metabolic and vascular insulin resistance in high-fat diet-induced obese rats. Journal of Functional Foods, 128, 106802. https://doi.org/10.1016/j.jff.2025.106802
Vancouver
Mutalub YB, Azemi AK, Suhaimi SQA, Rasool AHG, Tang SP, Lee C, et al. AB-kefir modulates gut microbiota and ameliorates obesity, metabolic and vascular insulin resistance in high-fat diet-induced obese rats. Journal of Functional Foods. 2025;128:106802. doi:10.1016/j.jff.2025.106802
BibTeX
@article{Mutalub2025,
author = {Mutalub, Yahkub Babatunde and Azemi, Ahmad Khusairi and Suhaimi, Siti Qusyasyiah Ahmad and Rasool, Aida Hanum Ghulam and Tang, Suk Peng and Lee, Chia-Chia and Mokhtar, Siti Safiah},
title = {AB-kefir modulates gut microbiota and ameliorates obesity, metabolic and vascular insulin resistance in high-fat diet-induced obese rats},
journal = {Journal of Functional Foods},
year = {2025},
volume = {128},
pages = {106802},
doi = {10.1016/j.jff.2025.106802}
}
EUVIMED